home / stock / snse / snse quote
Last: | $1.02 |
---|---|
Change Percent: | -3.99% |
Open: | $1.04 |
Close: | $1.02 |
High: | $1.04 |
Low: | $1 |
Volume: | 6,161 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.02 | $1.04 | $1.02 | $1.04 | $1 | 6,161 | 04-26-2024 |
$1.0001 | $0.9792 | $1.0001 | $1.065 | $0.9503 | 44,885 | 04-25-2024 |
$0.9917 | $1.04 | $0.9917 | $1.04 | $0.9401 | 54,562 | 04-24-2024 |
$0.9977 | $0.913 | $0.9977 | $1.1 | $0.913 | 85,180 | 04-23-2024 |
$0.9309 | $1.03 | $0.9309 | $1.05 | $0.9101 | 65,809 | 04-22-2024 |
$0.97 | $0.94 | $0.97 | $1.02 | $0.933 | 23,775 | 04-19-2024 |
$0.9829 | $0.9701 | $0.9829 | $1 | $0.96 | 31,548 | 04-18-2024 |
$1 | $0.9881 | $1 | $1.05 | $0.9702 | 36,705 | 04-17-2024 |
$0.9881 | $1.01 | $0.9881 | $1.08 | $0.96 | 57,772 | 04-16-2024 |
$1.005 | $1.05 | $1.005 | $1.05 | $1 | 35,642 | 04-15-2024 |
$1.05 | $1.1 | $1.05 | $1.1138 | $1.05 | 32,649 | 04-12-2024 |
$1.09 | $1.09 | $1.09 | $1.17 | $1.05 | 297,352 | 04-11-2024 |
$1.1 | $1.13 | $1.1 | $1.15 | $1.005 | 154,904 | 04-10-2024 |
$1.1 | $1.03 | $1.1 | $1.14 | $1.01 | 303,106 | 04-09-2024 |
$1.035 | $0.99 | $1.035 | $1.07 | $0.9611 | 42,733 | 04-08-2024 |
$1.01 | $0.97 | $1.01 | $1.08 | $0.952 | 192,558 | 04-05-2024 |
$0.99 | $0.9701 | $0.99 | $0.99 | $0.95 | 264,935 | 04-04-2024 |
$0.99 | $0.99 | $0.99 | $1.01 | $0.9572 | 56,968 | 04-03-2024 |
$0.99 | $1.05 | $0.99 | $1.09 | $0.9201 | 47,719 | 04-02-2024 |
$1.05 | $1.06 | $1.05 | $1.12 | $1.0302 | 24,636 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sensei Biotherapeutics Inc. Company Name:
SNSE Stock Symbol:
NASDAQ Market:
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that topline clinical data from the monotherapy and combin...
BOSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), an immuno-oncology company focused on the discovery and...
BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced the publication of a peer-reviewed research paper in Nat...